Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for CHARMAINE WILLIAMS�
25.71
+0.14 (0.55%)
Nov 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.32 - 25.94
52 week 18.42 - 30.97
Open 25.40
Vol / Avg. 56,694.00/134,325.00
Mkt cap 440.92M
P/E 37.10
Div/yield     -
EPS 0.69
Shares 17.18M
Beta 0.05
Inst. own 61%
Feb 2, 2015
Q4 2014 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 2, 2014
Vascular Solutions Inc at Piper Jaffray Healthcare Conference - 10:30AM EST - Add to calendar
Nov 20, 2014
Vascular Solutions Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 18, 2014
Vascular Solutions Inc at Stifel Healthcare Conference
Oct 21, 2014
Q3 2014 Vascular Solutions Inc Earnings Call
Oct 21, 2014
Q3 2014 Vascular Solutions Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 8.05% 10.08%
Operating margin 16.33% 14.57%
EBITD margin - 19.78%
Return on average assets 8.58% 11.36%
Return on average equity 9.71% 12.86%
Employees 406 -
CDP Score - -

Address

6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vascular Solutions, Inc. (Vascular) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists. Vascular offers product and service in three categories: catheter products, hemostat products and vein products and services. Catheter products consist of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions. Hemostat (blood clotting) products consist of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable. Vein products consist of the Vari-Lase endovenous laser. In December 2011, it acquired 5-year rights to sell reprocessing services for the ClosureFast catheter in the United States from Northeast Scientific, Inc. In June 2012, the Company acquired the radial artery access wrist positioning splint product assets of Accumed Systems, Inc.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Howard Root Chief Executive Officer and Director
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 40
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - Worldwide Sales
Age: 61
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Operations
Age: 54
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 45
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 39
Bio & Compensation  - Reuters
Phillip E Nalbone Vice President - Corporate Development
Age: 52
Bio & Compensation  - Reuters
Brett Demchuk Vice President - Product Quality
Age: 49
Bio & Compensation  - Reuters
Jonathan M. Hammond Vice President - Manufacturing Engineering
Age: 46
Bio & Compensation  - Reuters